Cargando…
Absent antibody production following COVID19 vaccination with mRNA in patients under immunosuppressive treatments
Patients undergoing immunosuppressive treatments have a higher need for protection against coronavirus disease (COVID19) that follows infection with the SARS-CoV-2 virus but their ability to respond sufficiently to COVID vaccines is uncertain. We retrospectively evaluated SARS-CoV-2 spike subunit 1...
Autores principales: | Wagner, Angelika, Jasinska, Joanna, Tomosel, Elena, Zielinski, Christoph C., Wiedermann, Ursula |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557974/ https://www.ncbi.nlm.nih.gov/pubmed/34785100 http://dx.doi.org/10.1016/j.vaccine.2021.10.068 |
Ejemplares similares
-
SARS-CoV-2-mRNA Booster Vaccination Reverses Non-Responsiveness and Early Antibody Waning in Immunocompromised Patients – A Phase Four Study Comparing Immune Responses in Patients With Solid Cancers, Multiple Myeloma and Inflammatory Bowel Disease
por: Wagner, Angelika, et al.
Publicado: (2022) -
Lack of seroprotection against diphtheria in the Austrian population, in light of reported diphtheria cases in Europe, 2022
por: Wagner, Angelika, et al.
Publicado: (2023) -
Enhanced and long term immunogenicity of a Her-2/neu multi-epitope vaccine conjugated to the carrier CRM197 in conjunction with the adjuvant Montanide
por: Tobias, Joshua, et al.
Publicado: (2017) -
Age-related differences in humoral and cellular immune responses after primary immunisation: indications for stratified vaccination schedules
por: Wagner, Angelika, et al.
Publicado: (2018) -
Course of Fecal Calprotectin after mRNA SARS-CoV-2 Vaccination in Patients with Inflammatory Bowel Diseases
por: Pokryszka, Jagoda, et al.
Publicado: (2022)